サマリー

Skin Disease is a general term for diseases that occur in the skin and skin accessory organs. There are many types of it, and visceral diseases can also be manifested on the skin.
There are many causes of skin diseases. For example, skin diseases caused by infectious factors, such as leprosy, scabies, fungal diseases, and skin bacterial infections, are often infectious, which not only affects physical health but also causes panic and social discrimination. With the improvement of living standards and the advancement of science and technology, infectious diseases such as leprosy have been significantly controlled worldwide.

Market Analysis and Insights: Global Skin Disease Treatment Market
The global Skin Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Disease Treatment market.

Global Skin Disease Treatment Scope and Market Size
Skin Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medicated Creams and Ointments
Antibiotics
Vitamins and Steroids
Antihistamines
Laser Therapy
Antifungals
Others

Segment by Application
Dermatology Clinics
Skincare Clinics
Hospitals
Aesthetic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
APEIRON Biologics AG
HanAll BioPharma
GlaxoSmithKline plc.
Allergen, Plc.
Anacor Pharmaceuticals
Celgene
Basilea Pharmaceutica
Cipher Pharmaceuticals
Agenus
Astion Pharma A/S
Bristol-Myers Squibb
Almirall S.A.
Galderma

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicated Creams and Ointments
1.2.3 Antibiotics
1.2.4 Vitamins and Steroids
1.2.5 Antihistamines
1.2.6 Laser Therapy
1.2.7 Antifungals
1.2.8 Others
1.3 Market by Application
1.3.1 Global Skin Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology Clinics
1.3.3 Skincare Clinics
1.3.4 Hospitals
1.3.5 Aesthetic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Skin Disease Treatment Market Perspective (2016-2027)
2.2 Skin Disease Treatment Growth Trends by Regions
2.2.1 Skin Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Skin Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Skin Disease Treatment Industry Dynamic
2.3.1 Skin Disease Treatment Market Trends
2.3.2 Skin Disease Treatment Market Drivers
2.3.3 Skin Disease Treatment Market Challenges
2.3.4 Skin Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Skin Disease Treatment Players by Revenue
3.1.1 Global Top Skin Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin Disease Treatment Revenue
3.4 Global Skin Disease Treatment Market Concentration Ratio
3.4.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2020
3.5 Skin Disease Treatment Key Players Head office and Area Served
3.6 Key Players Skin Disease Treatment Product Solution and Service
3.7 Date of Enter into Skin Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Skin Disease Treatment Breakdown Data by Type
4.1 Global Skin Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Skin Disease Treatment Breakdown Data by Application
5.1 Global Skin Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Skin Disease Treatment Market Size (2016-2027)
6.2 North America Skin Disease Treatment Market Size by Type
6.2.1 North America Skin Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Skin Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Skin Disease Treatment Market Size by Type (2016-2027)
6.3 North America Skin Disease Treatment Market Size by Application
6.3.1 North America Skin Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Skin Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Skin Disease Treatment Market Size by Application (2016-2027)
6.4 North America Skin Disease Treatment Market Size by Country
6.4.1 North America Skin Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Skin Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Skin Disease Treatment Market Size (2016-2027)
7.2 Europe Skin Disease Treatment Market Size by Type
7.2.1 Europe Skin Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Skin Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Skin Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Skin Disease Treatment Market Size by Application
7.3.1 Europe Skin Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Skin Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Skin Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Skin Disease Treatment Market Size by Country
7.4.1 Europe Skin Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Skin Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Skin Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Skin Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Skin Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Skin Disease Treatment Market Size (2016-2027)
9.2 Latin America Skin Disease Treatment Market Size by Type
9.2.1 Latin America Skin Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Skin Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Skin Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Skin Disease Treatment Market Size by Application
9.3.1 Latin America Skin Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Skin Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Skin Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Skin Disease Treatment Market Size by Country
9.4.1 Latin America Skin Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Skin Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Skin Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Skin Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Skin Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 APEIRON Biologics AG
11.1.1 APEIRON Biologics AG Company Details
11.1.2 APEIRON Biologics AG Business Overview
11.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction
11.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2016-2021)
11.1.5 APEIRON Biologics AG Recent Development
11.2 HanAll BioPharma
11.2.1 HanAll BioPharma Company Details
11.2.2 HanAll BioPharma Business Overview
11.2.3 HanAll BioPharma Skin Disease Treatment Introduction
11.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2016-2021)
11.2.5 HanAll BioPharma Recent Development
11.3 GlaxoSmithKline plc.
11.3.1 GlaxoSmithKline plc. Company Details
11.3.2 GlaxoSmithKline plc. Business Overview
11.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction
11.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline plc. Recent Development
11.4 Allergen, Plc.
11.4.1 Allergen, Plc. Company Details
11.4.2 Allergen, Plc. Business Overview
11.4.3 Allergen, Plc. Skin Disease Treatment Introduction
11.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2016-2021)
11.4.5 Allergen, Plc. Recent Development
11.5 Anacor Pharmaceuticals
11.5.1 Anacor Pharmaceuticals Company Details
11.5.2 Anacor Pharmaceuticals Business Overview
11.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction
11.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021)
11.5.5 Anacor Pharmaceuticals Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Skin Disease Treatment Introduction
11.6.4 Celgene Revenue in Skin Disease Treatment Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Basilea Pharmaceutica
11.7.1 Basilea Pharmaceutica Company Details
11.7.2 Basilea Pharmaceutica Business Overview
11.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction
11.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2016-2021)
11.7.5 Basilea Pharmaceutica Recent Development
11.8 Cipher Pharmaceuticals
11.8.1 Cipher Pharmaceuticals Company Details
11.8.2 Cipher Pharmaceuticals Business Overview
11.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction
11.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021)
11.8.5 Cipher Pharmaceuticals Recent Development
11.9 Agenus
11.9.1 Agenus Company Details
11.9.2 Agenus Business Overview
11.9.3 Agenus Skin Disease Treatment Introduction
11.9.4 Agenus Revenue in Skin Disease Treatment Business (2016-2021)
11.9.5 Agenus Recent Development
11.10 Astion Pharma A/S
11.10.1 Astion Pharma A/S Company Details
11.10.2 Astion Pharma A/S Business Overview
11.10.3 Astion Pharma A/S Skin Disease Treatment Introduction
11.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2016-2021)
11.10.5 Astion Pharma A/S Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Almirall S.A.
11.12.1 Almirall S.A. Company Details
11.12.2 Almirall S.A. Business Overview
11.12.3 Almirall S.A. Skin Disease Treatment Introduction
11.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2016-2021)
11.12.5 Almirall S.A. Recent Development
11.13 Galderma
11.13.1 Galderma Company Details
11.13.2 Galderma Business Overview
11.13.3 Galderma Skin Disease Treatment Introduction
11.13.4 Galderma Revenue in Skin Disease Treatment Business (2016-2021)
11.13.5 Galderma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details